Total Funding
79
10
Total FundingSeries A raised
Growth Score
-8 pts
Heat Score
-9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
649106
Rules-Based Medicine is a multiplexed immunoassay testing laboratory that provides comprehensive protein biomarker services.
Ralph L McDade: General ManagerPast Role: Myriad Genetics, President - Myriad RBM
About the Company
Rules-Based Medicine, a Q squared solutions company (RBM), the world's leading multiplexed biomarker testing laboratory, provides comprehensive protein biomarker products and services based on its Multi-Analyte Profiling (MAP) technology platform. RBM's biomarker testing service provides pre-clinical and clinical researchers with
reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins in a cost-effective manner, from a small sample volume and from multiple species. Their biomarker testing laboratory is CLIA certified and supports GLP studies.
